A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.
Shortages for low-cost injectable generic drugs and essential fluids vital to patient care remain a vulnerability.
As we emerge from the COVID-19 pandemic, bundled payments offer healthcare providers opportunities to improve performance and generate savings.
Now that we have a decade of MSSP data to study, we thought it would be interesting to revisit some of the predictions of 2012.
CMS’s estimates of hospital spending growth represented less than half the actual growth in the prices paid by hospitals for labor, supplies and services.
Laboratory testing is known to be a source of potential waste and overutilization. PINC AI™ Clinical Decision Support alerts provide insight into high-cost labs.
While inflation affects all industries, the problem is particularly challenging in healthcare. Premier is doing everything possible to keep inflation at bay for its members.
Premier's Ryan Nellis discusses the role of AI in value-based care and patient engagement.
Here are three ways life science companies can utilize real-world data and evidence derived from charge master data to provide value and improve outcomes.
As cost reduction efforts continue to escalate across the healthcare industry, some healthcare organizations are finding success in the AP department.
Healthcare data is challenging to manage efficiently because of its complexity and sheer volume.
Bundled payment programs are expected to continue and are likely to transition to mandatory tests of change. But participation doesn’t have to be daunting.
The value-based care movement has fueled the push to better measure healthcare quality.